Clinical Trial Update: Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases [NA]

View source ↗

Summary

A clinical trial is planned to evaluate the RayerKnife X Stereotactic Radiotherapy System for treating brain metastases, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• RayerKnife X Stereotactic Radiotherapy System

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Brain Metastasis, SRS | NA | Status: NOT_YET_RECRUITING